SELLAS Life Sciences (SLS) Net Cash Flow (2019 - 2024)
Historic Net Cash Flow for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $11.9 million.
- SELLAS Life Sciences' Net Cash Flow rose 22079.69% to $11.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $17.1 million, marking a year-over-year increase of 21467.17%. This contributed to the annual value of $11.4 million for FY2024, which is 17780.75% up from last year.
- Per SELLAS Life Sciences' latest filing, its Net Cash Flow stood at $11.9 million for Q3 2024, which was up 22079.69% from -$9.3 million recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Net Cash Flow high stood at $27.1 million for Q4 2020, and its period low was -$9.8 million during Q3 2023.
- Over the past 5 years, SELLAS Life Sciences' median Net Cash Flow value was -$3.4 million (recorded in 2020), while the average stood at $1.1 million.
- In the last 5 years, SELLAS Life Sciences' Net Cash Flow crashed by 126892.66% in 2021 and then surged by 81480.89% in 2022.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Net Cash Flow stood at $27.1 million in 2020, then plummeted by 118.18% to -$4.9 million in 2021, then grew by 14.27% to -$4.2 million in 2022, then skyrocketed by 65.92% to -$1.4 million in 2023, then skyrocketed by 925.85% to $11.9 million in 2024.
- Its Net Cash Flow was $11.9 million in Q3 2024, compared to -$9.3 million in Q2 2024 and $15.9 million in Q1 2024.